Partnerships
Collaboration is how oncology medicine moves forward.
PTC Oncology partners across industry, academia, healthcare and the international biotech ecosystem to accelerate the delivery of anti-cancer therapies.
Pharmaceutical Manufacturers
Formulation, process development and technology transfer support for oncology portfolios.
Universities & Research Institutes
Bench-to-bedside collaborations translating academic science into industrial pharmaceutical development.
NHS & Cancer Research Organisations
Partnering to accelerate access to next-generation anti-cancer medicines within the UK health system.
Biotechnology Companies
Working alongside biotech innovators to industrialise novel oncology therapeutics.
International Collaborators
Cross-border programmes connecting UK expertise with global pharmaceutical markets.
Contract Research Organisations
Complementary CRO relationships covering discovery, preclinical and clinical execution.
Featured Technical Partner
The Antibody Company (TAC)
TAC is a UK-based antibody specialist supporting biotech, diagnostics and research organisations. PTC Oncology and TAC deliver joint monoclonal antibody programmes — including the Nivolumab biosimilar — combining formulation and manufacturing technology with deep antibody science.